Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gianluca Spitaleri

Showing results (1-10 of 86) with videos related to

Pageof 9
Sort By:
The New England Journal of Medicine|December 13, 2006
Treatment of rectal cancerGiuseppe Curigliano, Gianluca Spitaleri, Giulia Zampino
Tumori|August 27, 2020
Interstitial pneumonitis in the COVID-19 era: a difficult differential diagnosis in patients with lung cancerChiara Catania, Valeria Stati, Gianluca Spitaleri
Clinical Lung Cancer|March 21, 2020
ReplyAntonio Passaro, Gianluca Spitaleri, Filippo de Marinis
Expert Review of Anticancer Therapy|July 9, 2016
First-line treatment in NSCLC harboring EGFR common mutations: EGFR TKI in monotherapy or in combination with anti-VEGF?Antonio Passaro, Gianluca Spitaleri, Filippo de Marinis
JAMA Oncology|August 16, 2019
The Desire for Life and Motherhood Despite Metastatic Lung CancerChiara Catania, Ester Del Signore, Gianluca Spitaleri
Chinese Clinical Oncology|December 12, 2018
Ensartinib (X-396) a novel drug for anaplastic lymphoma kinase-positive non-small cell lung cancer patients: we need smart trials to avoid wasting good bulletsGianluca Spitaleri, Antonio Passaro, Filippo de Marinis
I Supplementi Di Tumori : Official Journal of Societa Italiana Di Cancerologia ... [Et Al.]|April 8, 2004
[Chemoprevention in non-small cell lung carcinoma]Vincenzo Adamo, Gianluca Spitaleri, Rosalba Rossello, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 18, 2019
Immunotherapy in Non-Small-Cell Lung Cancer Patients With Performance Status 2: Clinical Decision Making With Scant EvidenceAntonio Passaro, Gianluca Spitaleri, Bishal Gyawali, et al.
Annals of Translational Medicine|November 4, 2020
Adjuvant EGFR TKIs in NSCLC harboring EGFR mutations: looking for a consensus wayIlaria Attili, Antonio Passaro, Lorenzo Spaggiari, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 28, 2010
Safety of concomitant administration of seasonal and/or H1N1 flu vaccination in patients receiving erlotinib for advanced non-small cell lung cancerGianluca Spitaleri, Angelo Delmonte, Francesca Toffalorio, et al.
Pageof 9

Showing results (1-10 of 86) with videos related to

Sort By:
Pageof 9
The New England Journal of Medicine|December 13, 2006
Treatment of rectal cancerGiuseppe Curigliano, Gianluca Spitaleri, Giulia Zampino
Tumori|August 27, 2020
Interstitial pneumonitis in the COVID-19 era: a difficult differential diagnosis in patients with lung cancerChiara Catania, Valeria Stati, Gianluca Spitaleri
Clinical Lung Cancer|March 21, 2020
ReplyAntonio Passaro, Gianluca Spitaleri, Filippo de Marinis
Expert Review of Anticancer Therapy|July 9, 2016
First-line treatment in NSCLC harboring EGFR common mutations: EGFR TKI in monotherapy or in combination with anti-VEGF?Antonio Passaro, Gianluca Spitaleri, Filippo de Marinis
JAMA Oncology|August 16, 2019
The Desire for Life and Motherhood Despite Metastatic Lung CancerChiara Catania, Ester Del Signore, Gianluca Spitaleri
Chinese Clinical Oncology|December 12, 2018
Ensartinib (X-396) a novel drug for anaplastic lymphoma kinase-positive non-small cell lung cancer patients: we need smart trials to avoid wasting good bulletsGianluca Spitaleri, Antonio Passaro, Filippo de Marinis
I Supplementi Di Tumori : Official Journal of Societa Italiana Di Cancerologia ... [Et Al.]|April 8, 2004
[Chemoprevention in non-small cell lung carcinoma]Vincenzo Adamo, Gianluca Spitaleri, Rosalba Rossello, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 18, 2019
Immunotherapy in Non-Small-Cell Lung Cancer Patients With Performance Status 2: Clinical Decision Making With Scant EvidenceAntonio Passaro, Gianluca Spitaleri, Bishal Gyawali, et al.
Annals of Translational Medicine|November 4, 2020
Adjuvant EGFR TKIs in NSCLC harboring EGFR mutations: looking for a consensus wayIlaria Attili, Antonio Passaro, Lorenzo Spaggiari, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|April 28, 2010
Safety of concomitant administration of seasonal and/or H1N1 flu vaccination in patients receiving erlotinib for advanced non-small cell lung cancerGianluca Spitaleri, Angelo Delmonte, Francesca Toffalorio, et al.
Pageof 9